Clinical trial
The Effect of a Natural Polyphenolic Extract From Pomegrnate (POMX) on the…
NCT00470808 · HaEmek Medical Center, Israel, Other · Unknown status
Key facts
| NCT number | NCT00470808 |
|---|---|
| Title | The Effect of a Natural Polyphenolic Extract From Pomegrnate (POMX) on the Development of Atherosclerosis in Diabetic Patients |
| Acronym | POMX |
| Lead sponsor | HaEmek Medical Center, Israel, Other |
| Status | Unknown status |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Atherosclerosis |
| Intervention type | Drug |
| Interventions | POMx |
| Start date | May 1, 2007 |
| Completion | Aug 1, 2007 |
| First posted | May 8, 2007 |
| Last update posted | May 8, 2007 |
| Countries | Israel |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: